As of 2024-12-12, the Relative Valuation of AVITA Medical Inc (RCEL) is (50.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.23 USD, the upside of AVITA Medical Inc based on Relative Valuation is -480.9%.
The range of the Relative Valuation is (47.18) - (44.03) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.6x - 31.4x | 26.5x |
| Forward P/E multiples | 19.1x - 20.1x | 19.6x |
| Fair Price | (47.18) - (44.03) | (50.39) |
| Upside | -456.6% - -432.8% | -480.9% |
| Date | P/E |
| 2024-11-29 | -5.86 |
| 2024-11-27 | -5.88 |
| 2024-11-26 | -5.90 |
| 2024-11-25 | -5.98 |
| 2024-11-22 | -6.10 |
| 2024-11-21 | -5.89 |
| 2024-11-20 | -5.97 |
| 2024-11-19 | -5.93 |
| 2024-11-18 | -5.69 |
| 2024-11-15 | -5.47 |
| 2024-11-14 | -5.75 |
| 2024-11-13 | -5.89 |
| 2024-11-12 | -5.79 |
| 2024-11-11 | -5.58 |
| 2024-11-08 | -5.47 |
| 2024-11-07 | -5.67 |
| 2024-11-06 | -5.58 |
| 2024-11-05 | -5.21 |
| 2024-11-04 | -5.11 |
| 2024-11-01 | -4.71 |
| 2024-10-31 | -4.62 |
| 2024-10-30 | -4.75 |
| 2024-10-29 | -4.73 |
| 2024-10-28 | -4.81 |
| 2024-10-25 | -4.63 |
| 2024-10-24 | -4.63 |
| 2024-10-23 | -4.75 |
| 2024-10-22 | -4.87 |
| 2024-10-21 | -4.81 |
| 2024-10-18 | -4.86 |
| 2024-10-17 | -4.79 |
| 2024-10-16 | -4.89 |
| 2024-10-15 | -4.77 |
| 2024-10-14 | -4.76 |
| 2024-10-11 | -4.72 |
| 2024-10-10 | -4.52 |
| 2024-10-09 | -4.63 |
| 2024-10-08 | -4.64 |
| 2024-10-07 | -4.78 |
| 2024-10-04 | -4.95 |
| 2024-10-03 | -4.94 |
| 2024-10-02 | -5.04 |
| 2024-10-01 | -4.83 |
| 2024-09-30 | -4.90 |
| 2024-09-27 | -4.91 |
| 2024-09-26 | -4.84 |
| 2024-09-25 | -4.76 |
| 2024-09-24 | -4.83 |
| 2024-09-23 | -4.83 |
| 2024-09-20 | -4.97 |